1. Home
  2. HIHO vs APVO Comparison

HIHO vs APVO Comparison

Compare HIHO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIHO
  • APVO
  • Stock Information
  • Founded
  • HIHO 1990
  • APVO 2016
  • Country
  • HIHO Hong Kong
  • APVO United States
  • Employees
  • HIHO N/A
  • APVO N/A
  • Industry
  • HIHO Industrial Machinery/Components
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIHO Industrials
  • APVO Health Care
  • Exchange
  • HIHO Nasdaq
  • APVO Nasdaq
  • Market Cap
  • HIHO 7.2M
  • APVO 4.1M
  • IPO Year
  • HIHO 1996
  • APVO N/A
  • Fundamental
  • Price
  • HIHO $1.63
  • APVO $3.00
  • Analyst Decision
  • HIHO
  • APVO Strong Buy
  • Analyst Count
  • HIHO 0
  • APVO 1
  • Target Price
  • HIHO N/A
  • APVO $5,920.00
  • AVG Volume (30 Days)
  • HIHO 7.8K
  • APVO 6.7M
  • Earning Date
  • HIHO 07-31-2025
  • APVO 08-07-2025
  • Dividend Yield
  • HIHO 7.32%
  • APVO N/A
  • EPS Growth
  • HIHO N/A
  • APVO N/A
  • EPS
  • HIHO 0.02
  • APVO N/A
  • Revenue
  • HIHO $7,412,000.00
  • APVO N/A
  • Revenue This Year
  • HIHO N/A
  • APVO N/A
  • Revenue Next Year
  • HIHO N/A
  • APVO N/A
  • P/E Ratio
  • HIHO $82.00
  • APVO N/A
  • Revenue Growth
  • HIHO 17.26
  • APVO N/A
  • 52 Week Low
  • HIHO $1.40
  • APVO $2.81
  • 52 Week High
  • HIHO $2.88
  • APVO $485.37
  • Technical
  • Relative Strength Index (RSI)
  • HIHO 38.43
  • APVO 34.83
  • Support Level
  • HIHO $1.55
  • APVO $2.89
  • Resistance Level
  • HIHO $1.69
  • APVO $3.20
  • Average True Range (ATR)
  • HIHO 0.05
  • APVO 0.27
  • MACD
  • HIHO -0.01
  • APVO 0.24
  • Stochastic Oscillator
  • HIHO 36.36
  • APVO 10.63

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: